High Dose Trifluoperazine Therapy in Chronic Schizophrenia
Abstract
This collaborative study on the efficacy of high doses of trifluoperazine in chronic schizophrenia showed that treatment response was related to length of hospitalization; short-term patients benefited most. High doses of trifluoperazine were most effective with those short-term patients who had been on a piperazine phenothiazine prior to the study. Also, most placebo patients who had been receiving low doses of phenothiazines before the study did not suffer deleterious effects while they were off medication. Treatment implications are discussed.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
